tiprankstipranks
Voyageur Pharmaceuticals (TSE:VM)
:VM
Canadian Market
Want to see TSE:VM full AI Analyst Report?

Voyageur Pharmaceuticals (VM) Financial Statements

20 Followers

Voyageur Pharmaceuticals Financial Overview

Voyageur Pharmaceuticals's market cap is currently C$18.75M. The company's EPS TTM is C$; its P/E ratio is -11.39; Voyageur Pharmaceuticals is scheduled to report earnings on April 24, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Feb 26Feb 25Feb 24Feb 23Feb 22
Income Statement
Total RevenueC$ 11.69KC$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -1.22MC$ -1.57KC$ -2.19KC$ -2.91KC$ -2.25K
Operating IncomeC$ -3.53MC$ -1.70MC$ -1.22MC$ -1.75MC$ -2.05M
EBITDAC$ -3.53MC$ -1.71MC$ -1.22MC$ -1.75MC$ -2.05M
Net IncomeC$ -3.53MC$ -1.71MC$ -1.40MC$ -1.75MC$ -2.05M
Balance Sheet
Cash & Short-Term InvestmentsC$ 267.05KC$ 165.57KC$ 2.08KC$ 31.56KC$ 812.97K
Total AssetsC$ 3.11MC$ 2.60MC$ 2.16MC$ 2.10MC$ 2.57M
Total DebtC$ 40.00KC$ 40.00KC$ 40.00KC$ 25.52KC$ 42.08K
Net DebtC$ -227.05KC$ -125.57KC$ 37.91KC$ -6.04KC$ -770.89K
Total LiabilitiesC$ 1.85MC$ 2.15MC$ 727.88KC$ 630.83KC$ 660.64K
Stockholders' EquityC$ 1.25MC$ 449.96KC$ 1.44MC$ 1.46MC$ 1.91M
Cash Flow
Free Cash FlowC$ -2.89MC$ -302.29KC$ -991.25KC$ -2.00MC$ -2.09M
Operating Cash FlowC$ -2.89MC$ -302.29KC$ -991.25KC$ -1.72MC$ -1.65M
Investing Cash FlowC$ -270.02KC$ -165.96KC$ -174.72KC$ -274.15KC$ -432.08K
Financing Cash FlowC$ 3.26MC$ 631.73KC$ 1.14MC$ 1.21MC$ 2.90M
Currency in CAD

Voyageur Pharmaceuticals Earnings and Revenue History

Voyageur Pharmaceuticals Debt to Assets

Voyageur Pharmaceuticals Cash Flow

Voyageur Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.